Johnson & Johnson to Showcase Strength of Its Broad Hematology Portfolio and Pipeline at the 2024 American Society of Hematology Annual Meeting
November 20, 2024
November 20, 2024
NEW BRUNSWICK, New Jersey, Nov. 20 (TNSres) -- Johnson and Johnson issued the following news release:
* * *
More than 90 presentations of clinical trial and real-world data highlight potentially practice-changing evidence and commitment to pioneer the next wave of therapies for patients with hematologic malignancies
* * *
RARITAN, NJ, November 19, 2024 - Johnson & Johnson (NYSE:JNJ) announced today more than 90 abstracts featuring data from . . .
* * *
More than 90 presentations of clinical trial and real-world data highlight potentially practice-changing evidence and commitment to pioneer the next wave of therapies for patients with hematologic malignancies
* * *
RARITAN, NJ, November 19, 2024 - Johnson & Johnson (NYSE:JNJ) announced today more than 90 abstracts featuring data from . . .